Yiqi Fumai injection in the treatment of chronic heart failure: an overview of systematic reviews_Chinese Journal of Evidence-Based Medicine

Authors：

FAN Maoxia ¹ ,  DAI Guohua ² , LI Runmin ¹ , REN Lili ¹

1. The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan 250014, P. R. China;
2. Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, P. R. China;

Corresponding?author：

DAI Guohua, Email: daiguohua202208@163.com

Keywords：

Yiqi Fumai injection; Chronic heart failure; Overview of systematic reviews

DOI：

10.7507/1672-2531.202211057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To overview of systematic reviews (SRs) of Yiqi Fumai (YQFM) injection in the treatment of chronic heart failure (CHF). Methods The PubMed, Cochrane Library, EMbase, Web of Science, CNKI, CBM and WanFang Data databases were electronically searched to collect SRs of YQFM injection in the treatment of CHF from January 1, 2007 to October 31, 2022. Two reviewers independently screened literature, extracted data and assessed methodological quality, risk of bias, report quality and evidence quality by using AMSTAR-2, ROBIS scale, PRISMA, and GRADE system. Results A total of 7 SRs were included. The evaluation results showed that the quality of all SRs was low, a few SRs were assessed as having a low risk of bias, and all SRs were relatively completely reported. A total of 46 results were extracted from the included SRs, including 3 with moderate quality evidence, 12 with low quality evidence and 31 with very low quality evidence. Conclusion YQFM may be an effective and safe treatment, but current evidence quality is low.

Citation： FAN Maoxia, DAI Guohua, LI Runmin, REN Lili. Yiqi Fumai injection in the treatment of chronic heart failure: an overview of systematic reviews. Chinese Journal of Evidence-Based Medicine, 2023, 23(5): 569-574. doi: 10.7507/1672-2531.202211057 Copy

1.	中國中西醫結合學會心血管疾病專業委員會, 中國醫師協會中西醫結合醫師分會心血管疾病專業委員會. 慢性心力衰竭中西醫結合診療專家共識. 心腦血管病防治, 2016, 16(5): 340-347.
2.	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint Committee on Clinical Practice Guidelines. Circulation, 2022, 145(18): e876-e894.
3.	褚延斌, 蘇小琴, 李德坤, 等. 基于一測多評法對注射用益氣復脈(凍干)中9種成分的質量控制研究. 中草藥, 2017, 48(17): 3537-3544.
4.	孟靜, 魯曉燕. 注射用益氣復脈(凍干)治療心力衰竭的藥理作用及臨床應用研究進展. 藥物評價研究, 2020, 43(8): 1506-1509.
5.	鞠愛春, 羅瑞芝, 蘇小琴, 等. 注射用益氣復脈(凍干)化學成分及質量控制研究進展. 藥物評價研究, 2018, 41(3): 365-371.
6.	鞠愛春, 羅瑞芝, 秦袖平, 等. 注射用益氣復脈(凍干)藥理作用及臨床研究進展. 藥物評價研究, 2018, 41(3): 354-364.
7.	Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 2021, 372: n160.
8.	陶歡, 楊樂天, 平安, 等. 隨機或非隨機防治性研究系統評價的質量評價工具AMSTAR 2解讀. 中國循證醫學雜志, 2018, 18(1): 101-108.
9.	吳瓊芳, 丁泓帆, 鄧圍, 等. ROBIS: 評估系統評價偏倚風險的新工具. 中國循證醫學雜志, 2015, 15(12): 1454-1457.
10.	Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
11.	連寶濤, 李澤彰, 陳嘉城, 等. 益氣復脈注射液治療心力衰竭的系統評價. 中國實驗方劑學雜志, 2016, 22(8): 215-220.
12.	王賢良, 馬寧, 侯雅竹, 等. 注射用益氣復脈(凍干)聯合西藥常規治療慢性心力衰竭療效的Meta分析. 中醫雜志, 2016, 57(5): 391-395.
13.	周麗, 范芳芳, 帕提古麗·阿卜杜力, 等. 益氣復脈注射液治療心力衰竭有效性和安全性的Meta分析. 中國醫藥導報, 2016, 13(22): 93-96,104.
14.	熊堯, 徐程, 陳嘉音, 等. 注射用益氣復脈(凍干)治療心力衰竭的Meta分析. 沈陽藥科大學學報, 2017, 34(5): 428-435.
15.	謝娜, 戴小華. 注射用益氣復脈(凍干)治療心力衰竭療效的Meta分析. 中西醫結合心腦血管病雜志, 2019, 17(10): 1499-1503.
16.	Nie H, Li S, Liu M, et al. Yiqi Fumai injection as an adjuvant therapy in treating chronic heart failure: a meta-analysis of 33 randomized controlled trials. Evid Based Complement Alternat Med, 2020, 2020: 1876080.
17.	樊根豪, 邢作英, 劉夢琳, 等. 注射用益氣復脈(凍干)治療心力衰竭有效性及安全性的系統評價和試驗序貫分析. 實用中醫內科雜志, 2021, 35(1): 8-18.
18.	周國鋒, 李媛, 林芮, 等. 中藥注射劑治療心力衰竭系統評價再評價. 中華中醫藥學刊, 2019, 37(1): 125-129.
19.	陳煒堅, 陳慕鏇, 林挺, 等. 中藥注射劑治療心律失常的系統評價再評價. 中國醫院藥學雜志, 2020, 40(23): 2445-2452.
20.	黃帆, 趙思怡, 戴琳, 等. 運用雷達圖對針灸治療原發性骨質疏松癥的系統評價再評價. 中國循證醫學雜志, 2019, 19(5): 602-608.
21.	楊繼, 張垚, 高晟瑋, 等. 麝香保心丸治療冠心病心絞痛系統評價的再評價. 中國中醫急癥, 2021, 30(5): 785-789.
22.	劉亦琳, 徐桂興, 黃柳楊, 等. 針灸治療支氣管哮喘的系統評價再評價. 中國循證醫學雜志, 2022, 22(8): 955-963.
23.	Yang K, Liu Y, Yuan J. Re-evaluation of systematic reviews in development and improvement. Chin J Evid Ped, 2011, 6(1): 54-57.
24.	歐陽嘉慧, 張淼, 王婭, 等. 中藥治療心力衰竭合并心律失常的系統評價再評價. 時珍國醫國藥, 2021, 32(5): 1272-1276.
25.	王虎城, 楊豐文, 龐穩泰, 等. 參附注射液治療心力衰竭的系統評價再評價. 中國中醫急癥, 2020, 29(1): 41-45,57.

1. 中國中西醫結合學會心血管疾病專業委員會, 中國醫師協會中西醫結合醫師分會心血管疾病專業委員會. 慢性心力衰竭中西醫結合診療專家共識. 心腦血管病防治, 2016, 16(5): 340-347.
2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint Committee on Clinical Practice Guidelines. Circulation, 2022, 145(18): e876-e894.
3. 褚延斌, 蘇小琴, 李德坤, 等. 基于一測多評法對注射用益氣復脈(凍干)中9種成分的質量控制研究. 中草藥, 2017, 48(17): 3537-3544.
4. 孟靜, 魯曉燕. 注射用益氣復脈(凍干)治療心力衰竭的藥理作用及臨床應用研究進展. 藥物評價研究, 2020, 43(8): 1506-1509.
5. 鞠愛春, 羅瑞芝, 蘇小琴, 等. 注射用益氣復脈(凍干)化學成分及質量控制研究進展. 藥物評價研究, 2018, 41(3): 365-371.
6. 鞠愛春, 羅瑞芝, 秦袖平, 等. 注射用益氣復脈(凍干)藥理作用及臨床研究進展. 藥物評價研究, 2018, 41(3): 354-364.
7. Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 2021, 372: n160.
8. 陶歡, 楊樂天, 平安, 等. 隨機或非隨機防治性研究系統評價的質量評價工具AMSTAR 2解讀. 中國循證醫學雜志, 2018, 18(1): 101-108.
9. 吳瓊芳, 丁泓帆, 鄧圍, 等. ROBIS: 評估系統評價偏倚風險的新工具. 中國循證醫學雜志, 2015, 15(12): 1454-1457.
10. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
11. 連寶濤, 李澤彰, 陳嘉城, 等. 益氣復脈注射液治療心力衰竭的系統評價. 中國實驗方劑學雜志, 2016, 22(8): 215-220.
12. 王賢良, 馬寧, 侯雅竹, 等. 注射用益氣復脈(凍干)聯合西藥常規治療慢性心力衰竭療效的Meta分析. 中醫雜志, 2016, 57(5): 391-395.
13. 周麗, 范芳芳, 帕提古麗·阿卜杜力, 等. 益氣復脈注射液治療心力衰竭有效性和安全性的Meta分析. 中國醫藥導報, 2016, 13(22): 93-96,104.
14. 熊堯, 徐程, 陳嘉音, 等. 注射用益氣復脈(凍干)治療心力衰竭的Meta分析. 沈陽藥科大學學報, 2017, 34(5): 428-435.
15. 謝娜, 戴小華. 注射用益氣復脈(凍干)治療心力衰竭療效的Meta分析. 中西醫結合心腦血管病雜志, 2019, 17(10): 1499-1503.
16. Nie H, Li S, Liu M, et al. Yiqi Fumai injection as an adjuvant therapy in treating chronic heart failure: a meta-analysis of 33 randomized controlled trials. Evid Based Complement Alternat Med, 2020, 2020: 1876080.
17. 樊根豪, 邢作英, 劉夢琳, 等. 注射用益氣復脈(凍干)治療心力衰竭有效性及安全性的系統評價和試驗序貫分析. 實用中醫內科雜志, 2021, 35(1): 8-18.
18. 周國鋒, 李媛, 林芮, 等. 中藥注射劑治療心力衰竭系統評價再評價. 中華中醫藥學刊, 2019, 37(1): 125-129.
19. 陳煒堅, 陳慕鏇, 林挺, 等. 中藥注射劑治療心律失常的系統評價再評價. 中國醫院藥學雜志, 2020, 40(23): 2445-2452.
20. 黃帆, 趙思怡, 戴琳, 等. 運用雷達圖對針灸治療原發性骨質疏松癥的系統評價再評價. 中國循證醫學雜志, 2019, 19(5): 602-608.
21. 楊繼, 張垚, 高晟瑋, 等. 麝香保心丸治療冠心病心絞痛系統評價的再評價. 中國中醫急癥, 2021, 30(5): 785-789.
22. 劉亦琳, 徐桂興, 黃柳楊, 等. 針灸治療支氣管哮喘的系統評價再評價. 中國循證醫學雜志, 2022, 22(8): 955-963.
23. Yang K, Liu Y, Yuan J. Re-evaluation of systematic reviews in development and improvement. Chin J Evid Ped, 2011, 6(1): 54-57.
24. 歐陽嘉慧, 張淼, 王婭, 等. 中藥治療心力衰竭合并心律失常的系統評價再評價. 時珍國醫國藥, 2021, 32(5): 1272-1276.
25. 王虎城, 楊豐文, 龐穩泰, 等. 參附注射液治療心力衰竭的系統評價再評價. 中國中醫急癥, 2020, 29(1): 41-45,57.

Chinese Journal of Evidence-Based Medicine

Yiqi Fumai injection in the treatment of chronic heart failure: an overview of systematic reviews

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content